93 related articles for article (PubMed ID: 31133463)
1. Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series.
Bamias A; Hegele A; Medioni J; Castellano D; Doni L; Passalacqua R; Zagouri F; Tzannis K; Hussain S; Ullen A
Crit Rev Oncol Hematol; 2019 Aug; 140():80-87. PubMed ID: 31133463
[TBL] [Abstract][Full Text] [Related]
2. Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study.
Abdel-Malek R; Shohdy KS; Abbas N; Ismail M; Hamada E; Abdel-Kader Y
Curr Drug Saf; 2019; 14(1):31-36. PubMed ID: 30277164
[TBL] [Abstract][Full Text] [Related]
3. Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
Passalacqua R; Lazzarelli S; Donini M; Montironi R; Tambaro R; De Giorgi U; Pignata S; Palumbo R; Ceresoli GL; Del Conte G; Tonini G; Morelli F; Nolè F; Panni S; Rondini E; Guida A; Zucali PA; Doni L; Iezzi E; Caminiti C
BMC Cancer; 2017 Jul; 17(1):493. PubMed ID: 28724419
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.
Bellmunt J; Théodore C; Demkov T; Komyakov B; Sengelov L; Daugaard G; Caty A; Carles J; Jagiello-Gruszfeld A; Karyakin O; Delgado FM; Hurteloup P; Winquist E; Morsli N; Salhi Y; Culine S; von der Maase H
J Clin Oncol; 2009 Sep; 27(27):4454-61. PubMed ID: 19687335
[TBL] [Abstract][Full Text] [Related]
5. Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy.
Krzakowski M; Ramlau R; Jassem J; Szczesna A; Zatloukal P; Von Pawel J; Sun X; Bennouna J; Santoro A; Biesma B; Delgado FM; Salhi Y; Vaissiere N; Hansen O; Tan EH; Quoix E; Garrido P; Douillard JY
J Clin Oncol; 2010 May; 28(13):2167-73. PubMed ID: 20351334
[TBL] [Abstract][Full Text] [Related]
6. A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.
Chan S; Campone M; Santoro A; Conte PF; Bostnavaron M; Nguyen L
Cancer Chemother Pharmacol; 2014 May; 73(5):903-10. PubMed ID: 24627219
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.
Médioni J; Di Palma M; Guillot A; Spaeth D; Théodore C
BMC Cancer; 2016 Mar; 16():217. PubMed ID: 26975779
[TBL] [Abstract][Full Text] [Related]
8. Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.
De Luca R; Profita G; Vella M; Cicero G
Oncology; 2019; 97(6):341-347. PubMed ID: 31461721
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Campone M; Isambert N; Bourbouloux E; Roché H; Bonneterre J; Milano G; Fumoleau P
Cancer Chemother Pharmacol; 2012 Apr; 69(4):871-9. PubMed ID: 22045498
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with pemetrexed and vinflunine in patients with metastatic urothelial cell carcinoma after prior platinum-containing chemotherapy - results of an exploratory phase I study.
Pappot H; von der Maase H; Ullén A; Agerbæk M;
Invest New Drugs; 2018 Aug; 36(4):615-618. PubMed ID: 29081023
[TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
Castellano D; Puente J; de Velasco G; Chirivella I; López-Criado P; Mohedano N; Fernández O; García-Carbonero I; González MB; Grande E
BMC Cancer; 2014 Oct; 14():779. PubMed ID: 25342282
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy.
Gerullis H; Eimer C; Ecke TH; Georgas E; Arndt C; Otto T
Anticancer Drugs; 2013 Apr; 24(4):422-5. PubMed ID: 23407060
[TBL] [Abstract][Full Text] [Related]
13. A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.
Zaman K; Durando X; Baurain JF; Humblet Y; Mazzeo F; Bostnavaron M; Meheust N; Monnoyer-Favrel S; Machiels JP; Bauer J
Breast Cancer Res Treat; 2011 Jun; 127(3):689-96. PubMed ID: 21442199
[TBL] [Abstract][Full Text] [Related]
14. Vinflunine in the Treatment of Upper Tract Urothelial Carcinoma - Subgroup Analysis of an Observational Study.
Heers H; DE Geeter P; Goebell PJ; Matz U; DE Schultz W; Edlich B; Retz M; Hegele A
Anticancer Res; 2017 Nov; 37(11):6437-6442. PubMed ID: 29061830
[TBL] [Abstract][Full Text] [Related]
15. [Vinflunine: still an option for patients with advanced urothelial carcinoma following immune-checkpoint inhibitors?].
Banna GL; Rundo F; Lipari H; Di Quattro R; Urzia V; Libra M; Malatino L
Recenti Prog Med; 2019 Dec; 110(12):615-618. PubMed ID: 31909764
[TBL] [Abstract][Full Text] [Related]
16. Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review.
Gerullis H; Ecke T; Eimer C; Wishahi M; Otto T
Anticancer Drugs; 2011 Jan; 22(1):9-17. PubMed ID: 20948429
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.
Pistamaltzian N; Tzannis K; Pissanidou V; Peroukidis S; Milaki G; Karavasilis V; Mitsogiannis I; Varkarakis I; Papatsoris A; Dellis A; Adamakis I; Stravodimos K; Molyva D; Athanasiadis I; Androulakis N; Andreadis C; Kalofonos C; Mitropoulos D; Deliveliotis C; Constantinides C; Dimopoulos MA; Bamias A
Anticancer Drugs; 2016 Jan; 27(1):48-53. PubMed ID: 26421462
[TBL] [Abstract][Full Text] [Related]
18. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Bellmunt J; de Wit R; Vaughn DJ; Fradet Y; Lee JL; Fong L; Vogelzang NJ; Climent MA; Petrylak DP; Choueiri TK; Necchi A; Gerritsen W; Gurney H; Quinn DI; Culine S; Sternberg CN; Mai Y; Poehlein CH; Perini RF; Bajorin DF;
N Engl J Med; 2017 Mar; 376(11):1015-1026. PubMed ID: 28212060
[TBL] [Abstract][Full Text] [Related]
19. Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.
Retz M; de Geeter P; Goebell PJ; Matz U; de Schultz W; Hegele A
BMC Cancer; 2015 Jun; 15():455. PubMed ID: 26040470
[TBL] [Abstract][Full Text] [Related]
20. Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series.
Palumbo R; Licata L; Sottotetti F; Tagliaferri B; Pozzi E; Teragni C; Quaquarini E; Bernardo A
Oncol Res Treat; 2018; 41(1-2):8-13. PubMed ID: 29402855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
